A Phase II Study of Depsipeptide, a Histone Deacetylase Inhibitor, in Relapsed or Refractory Mantle Cell or Diffuse Large Cell Non-Hodgkin's Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 30 Oct 2013
At a glance
- Drugs Romidepsin (Primary)
- Indications Diffuse large B cell lymphoma; Mantle-cell lymphoma
- Focus Therapeutic Use
- 30 Apr 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 20 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 May 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.